A patient that was started on olanzapine (Zyprexa) – a secon…
A patient that was started on olanzapine (Zyprexa) – a second generation atypical antipsychotic – one month ago comes into the clinic for a follow-up appointment. The healthcare provider (HCP) wants to observe the patient to determine if they are presenting with the life-threatening side effect associated with this medication. What clinical manifestations would you anticipate to see if the patient is presenting with this life-threating side effect? Note: Full credit can only be obtained only if all correct choices are selected.